1. Home
  2. Directory
  3. Missouri
  4. Kansas City
  5. Radiology
  6. NPI Profile
  7. Prescriptions 1104048933

MELISA G BOERSMA MD
Prescription History 1104048933
Radiology - Radiation Oncology in Kansas City, MO


Quality Rating: 97.58 out of 100 score

NPI Status: Active since May 02, 2007

Contact Information

8700 N GREEN HILLS RD
KANSAS CITY, MO
ZIP 64154
Phone: (913) 574-2520

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MELISA G BOERSMA MD, an active Radiation Oncology specialist practicing in Kansas City, MO. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 79 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 28 claims alone.

Medication Index

F
G
S
T
No matching medications currently found on file.

Fluconazole

Generic Formulation: FluconazoleSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.0
Days Supply 212
MO State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills23.9
Peer Average Days Supply248
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $276.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.82

State Avg Cost Per Claim

$13.46

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.

Therapeutic Applications

Fluconazole is used to treat vaginal yeast infections. It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals.

Gabapentin

Generic Formulation: GabapentinSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 28
30-Day Fills 43.2
Days Supply 1,167
MO State Average Benchmarks
Peer Average Claims115.0
Peer Average 30-Day Fills176.1
Peer Average Days Supply5,091
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.7% less volume than the regional standard for practitioners inside MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $680.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.29

State Avg Cost Per Claim

$23.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Silver Sulfadiazine

Generic Formulation: Silver SulfadiazineSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 13
30-Day Fills 20.3
Days Supply 610
MO State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills21.4
Peer Average Days Supply469
Conservative Utilization

This provider writes prescriptions for this formulation 31.6% less frequently than the standard regional baseline metric for practitioners inside MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $388.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.88

State Avg Cost Per Claim

$19.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Antibacterial used topically in burn therapy.

Therapeutic Applications

This medication is used with other treatments to help prevent and treat wound infections in patients with serious burns. Silver sulfadiazine works by stopping the growth of bacteria that may infect an open wound. This helps to decrease the risk of the bacteria spreading to surrounding skin, or to the blood where it can cause a serious blood infection (sepsis). Silver sulfadiazine belongs to a class of drugs known as sulfa antibiotics. Silver sulfadiazine must not be used on premature babies or on newborns during the first 2 months of life because of the risk of serious side effects.

Tamsulosin Hcl

Generic Formulation: Tamsulosin HclSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 18
30-Day Fills 47.0
Days Supply 1,410
MO State Average Benchmarks
Peer Average Claims100.0
Peer Average 30-Day Fills209.6
Peer Average Days Supply6,141
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 82.0% less volume than the regional standard for practitioners inside MO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $457.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.44

State Avg Cost Per Claim

$18.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MELISA G BOERSMA MD provides transparency into local medical care patterns within Kansas City, MO.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Radiation Oncology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.